ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity

Journal of Lipid Research

Volumn 55, Issue 3, 2014, Pages 516-523

  De Haan, Willeke ^a   Bhattacharjee, Alpana ^a   Ruddle, Piers ^a   Kang, Martin H ^a   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ATP binding cassette transporter A1; Cholesterol; Glucose homeostasis; Insulin resistance; Lipid metabolism; Obesity; Type 2 diabetes

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ADIPONECTIN; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ABCG1 GENE; ADIPOCYTE; ADIPONECTIN GENE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUT4 GENE; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LDLR GENE; LEPTIN GENE; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

ATP BINDING CASSETTE TRANSPORTER A1; CHOLESTEROL; GLUCOSE HOMEOSTASIS; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; TYPE 2 DIABETES;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; GENE EXPRESSION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 84894822714     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M045294     Document Type: Article

References (34)

1. Rasouli, N., and P. A. Kern. 2008. Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 93: S64-S73.
2. Galic, S., J. S. Oakhill, and G. R. Steinberg. 2010. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 316: 129-139.
3. Yu, B-L., S-P. Zhao, and J-R. Hu. 2010. Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity. Obes. Rev. 11: 560-567.
4. Kovanen, P. T., E. A. Nikkilä, and T. A. Miettinen. 1975. Regulation of cholesterol synthesis and storage in fat cells. J. Lipid Res. 16: 211-223.
5. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009. (Pubitemid 24266467)
6. Young, S. G., and R. Zechner. 2013. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 27: 459-484.
7. Le Lay, S., C. Robichon, X. Le Liepvre, G. Dagher, P. Ferre, and I. Dugail. 2003. Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells. J. Lipid Res. 44: 1499-1507. (Pubitemid 37279594)
8. Howard, A. D., P. B. Verghese, E. L. Arrese, and J. L. Soulages. 2010. Characterization of apoA-I-dependent lipid efflux from adipocytes and role of ABCA1. Mol. Cell. Biochem. 343: 115-124.
9. McNeish, J., R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA. 97: 4245-4250. (Pubitemid 30226118)
10. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345. (Pubitemid 29369523)
11. Wellington, C. L., E. K. Y. Walker, A. Suarez, A. Kwok, N. Bissada, R. Singaraja, Y-Z. Yang, L-H. Zhang, E. James, J. E. Wilson, et al. 2002. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab. Invest. 82: 273-283. (Pubitemid 34242521)
12. Karasinska, J. M., F. Rinninger, D. Lütjohann, P. Ruddle, S. Franciosi, J. K. Kruit, R. R. Singaraja, V. Hirsch-Reinshagen, J. Fan, L. R. Brunham, et al. 2009. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 29: 3579-3589.
13. Brunham, L. R., J. K. Kruit, T. D. Pape, J. M. Timmins, A. Q. Reuwer, Z. Vasanji, B. J. Marsh, B. Rodrigues, J. D. Johnson, J. S. Parks, et al. 2007. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat. Med. 13: 340-347. (Pubitemid 46376682)
14. Brunham, L. R., R. R. Singaraja, T. D. Pape, A. Kejariwal, P. D. Thomas, and M. R. Hayden. 2005. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet. 1: e83.
15. Chung, S., J. K. Sawyer, A. K. Gebre, N. Maeda, and J. S. Parks. 2011. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo. Circulation. 124: 1663-1672.
16. Le Lay, S., S. Krief, C. Farnier, I. Lefrère, X. Le Liepvre, R. Bazin, P. Ferré, and I. Dugail. 2001. Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J. Biol. Chem. 276: 16904-16910.
17. Dugail, I., S. Le Lay, M. Varret, X. Le Liepvre, G. Dagher, and P. Ferré. 2003. New insights into how adipocytes sense their triglyceride stores. Is cholesterol a signal? Horm. Metab. Res. 35: 204-210. (Pubitemid 36754195)
18. Blüher, M. 2009. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes. 117: 241-250.
19. Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9: 367-377. (Pubitemid 351574198)
20. Henry, S. L., J. G. Bensley, R. J. Wood-Bradley, L. A. Cullen-McEwen, J. F. Bertram, and J. A. Armitage. 2012. White adipocytes: more than just fat depots. Int. J. Biochem. Cell Biol. 44: 435-440.
21. Angulo, P. 2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346: 1221-1231.
22. van der Hoorn, J. W. A., W. de Haan, J. F. P. Berbée, L. M. Havekes, J. W. Jukema, P. C. N. Rensen, and H. M. G. Princen. 2008. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice. Arterioscler. Thromb. Vasc. Biol. 28: 2016-2022.
23. Zelcer, N., and P. Tontonoz. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116: 607-614. (Pubitemid 43326865)
24. Kennedy, M. A., G. C. Barrera, K. Nakamura, A. Baldán, P. Tarr, M. C. Fishbein, J. Frank, O. L. Francone, and P. A. Edwards. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1: 121-131. (Pubitemid 43977167)
25. Brown, M. S., S. E. Dana, and J. L. Goldstein. 1975. Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc. Natl. Acad. Sci. USA. 72: 2925-2929.
26. Brown, M. S., and J. L. Goldstein. 1974. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science. 185: 61-63.
27. McFie, P. J., S. L. Banman, S. Kary, and S. J. Stone. 2011. Murine diacylglycerol acyltransferase-2 (DGAT2) can catalyze triacylglycerol synthesis and promote lipid droplet formation independent of its localization to the endoplasmic reticulum. J. Biol. Chem. 286: 28235-28246.
28. Franssen, R., H. Monajemi, E. S. G. Stroes, and J. J. P. Kastelein. 2011. Obesity and dyslipidemia. Med. Clin. North Am. 95: 893-902.
29. Abel, E. D., O. Peroni, J. K. Kim, Y. B. Kim, O. Boss, E. Hadro, T. Minnemann, G. I. Shulman, and B. B. Kahn. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409: 729-733. (Pubitemid 32144519)
30. Tripathy, D., K. F. Eriksson, M. Orho-Melander, J. Fredriksson, G. Ahlqvist, and L. Groop. 2004. Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in type 2 diabetes. Diabetologia. 47: 782-793. (Pubitemid 38756990)
31. Kahn, S. E. 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 46: 3-19. (Pubitemid 36237741)
32. Savage, D. B. 2009. Mouse models of inherited lipodystrophy. Dis. Model. Mech. 2: 554-562.
33. Tripathy, D., and A. O. Chavez. 2010. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr. Diab. Rep. 10: 184-191.
34. Butler, A. E., J. Janson, W. C. Soeller, and P. C. Butler. 2003. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes. 52: 2304-2314. (Pubitemid 37059501)